Hologic Inc. recently released the transcript from their participation at the William Blair 45th Annual Growth Stock Conference, held on June 4, 2025. The event was attended by Hologic's Chief Financial Officer, Karleen Oberton, and Peter Sattler from Investor Relations, alongside Andrew Brackmann, a diagnostics analyst from William Blair. During the conference, Karleen Oberton highlighted Hologic's dedication to women's healthcare, emphasizing their market-leading products that set the "gold standard of care." She noted the company's engagement in the global women's health index with Gallup, which helps measure progress in women's health and facilitates discussions with health ministries globally. Oberton also addressed the challenges faced by Hologic, including macroeconomic headwinds and the impact of halted USAID funding on their HIV business in Sub-Saharan Africa, which previously generated $50 million annually. Despite these challenges, Oberton expressed confidence in the company's growth trajectory, particularly in their diagnostics sector, stating, "Diagnostics, again, is leading growth. We see continued strong momentum in the Diagnostics business, given the Panther utilization, our installed base, and our growing menu." The full transcript can be accessed through the link below.